Dr. Mai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
Johns Hopkins UniversityResidency, Internal Medicine, 2019 - 2022- Johns Hopkins University School of MedicineClass of 2019
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsHospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.Sarah Z. Hazell, Nicholas Mai, Wei Fu, Chen Hu, Cole Friedes
BMC Cancer. 2020-04-19 - 23 citationsSelectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potencyJulie Farand, Nicholas Mai, Jayaraman Chandrasekhar, Zachary Newby, Josh Van Veldhuizen
Bioorganic & Medicinal Chemistry Letters. 2016-12-15 - 10 citationsIsolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy.Cole Friedes, Nicholas Mai, Wei Fu, Chen Hu, Sarah Z. Hazell
Cancer. 2020-10-15
Journal Articles
- Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai et al, NPJ Breast, 2024
- Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai et al, NPJ Breast, 2024
- Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai etal, NPJ Precision Oncology, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
